Research News for November 2008
1–7 of 7 articles
-
Xeloda and Avastin Combo Better Than Xeloda Alone for Metastatic Disease
The combination of Xeloda (chemical name: capecitabine) and Avastin (chemical name: bevacizumab) has been shown to stop metastatic breast cancer from growing longer than Xeloda alone.
-
Reconstruction with Implant Immediately After Mastectomy Affected More by Radiation
A small study suggests that reconstruction done immediately after mastectomy using tissue from the body offers better results after radiation compared to immediate reconstruction using implants.
-
Some Cancers May Go Away Without Treatment
A Norwegian study suggests that some breast cancers may go away without treatment, but the hypothesis is controversial and the results should be carefully considered.
-
Factors Besides Treatment Likely Contribute to Survivors’ Bone Loss
A small study shows that other factors besides breast cancer treatment contribute to bone loss in post-menopausal women.
-
Avastin Ups Blood Clot Risk
New research suggests that Avastin increases the risk of a blood clot in a vein, but the risk varies depending on the type of cancer being treated.
-
Calcium and Vitamin D Supplements Don’t Reduce Risk in Postmenopausal Women
Results from the Women's Health Initiative study suggest that vitamin D and calcium supplements don't lower breast cancer risk.
-
Can Migraine Cause Protect Against Breast Cancer?
Women who get migraine headaches appear to have a lower risk of breast cancer compared to women who don't get migraines.
1–7 of 7 articles
